Pages that link to "Q54027485"

The following pages link to Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. (Q54027485):

Displaying 25 items.

• The zebrafish as a model for studying neuroblastoma (Q28070309) (← links)
• Lack of correlation between MYCN expression and the Warburg effect in neuroblastoma cell lines (Q33369231) (← links)
• Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression (Q33702245) (← links)
• mCLCA3 modulates IL-17 and CXCL-1 induction and leukocyte recruitment in murine Staphylococcus aureus pneumonia (Q33916302) (← links)
• Myc proteins as therapeutic targets (Q33997741) (← links)
• Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma (Q34066263) (← links)
• Neuroblastoma: biological insights into a clinical enigma (Q34180699) (← links)
• Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma. (Q34398691) (← links)
• Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma (Q34531771) (← links)
• Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma (Q35106297) (← links)
• Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo (Q35158209) (← links)
• An unexpected role for caspase-2 in neuroblastoma. (Q35679550) (← links)
• The Goblet Cell Protein Clca1 (Alias mClca3 or Gob-5) Is Not Required for Intestinal Mucus Synthesis, Structure and Barrier Function in Naive or DSS-Challenged Mice (Q35688253) (← links)
• N-myc transcription molecule and oncoprotein (Q35733159) (← links)
• Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice. (Q36673633) (← links)
• Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction (Q36944205) (← links)
• β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. (Q36959073) (← links)
• Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas (Q37288916) (← links)
• Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. (Q37494210) (← links)
• Genetically engineered murine models – Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma (Q37940719) (← links)
• Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages (Q39637537) (← links)
• Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. (Q41592643) (← links)
• Soluble mucus component CLCA1 modulates expression of leukotactic cytokines and BPIFA1 in murine alveolar macrophages but not in bone marrow-derived macrophages. (Q52333866) (← links)
• A simple method for the isolation of genomic DNA from mouse tail free of real-time PCR inhibitors (Q74692872) (← links)
• Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition (Q91763766) (← links)